2FIRSTS Named Global Media Partner for IECIE Indonesia Vape Expo

Oct.12.2022
2FIRSTS Named Global Media Partner for IECIE Indonesia Vape Expo
2FIRSTS becomes the exclusive global cooperation media of IECIE in the Indonesia market for e-cigarettes.

On October 17th, 2022, 2FIRSTS International Station (www.2firsts.com) and IECIE jointly announced that 2FIRSTS has officially become the exclusive global media partner of the IECIE Electronic Cigarette Exhibition in Jakarta, Indonesia.


2FIRSTS has been named as the global cooperative media for the IECIE Indonesia exhibition.


Prior to this collaboration, 2FIRSTS had already established a strong working relationship with IECIE. On December 7th, 2021, during the IECIE Vape Expo Peak Forum, which focused on the trends and advancements in the electronic vaping industry, 2FIRSTS' co-founders and CEO, Zhao Tong, and COO, Guo Xiaoyu, in partnership with IECIE, launched the "2021 China E-Cigarette Retail Industry Blue Book".


Zhao Tong, the co-founder and CEO of 2FIRSTS, unveiled the "2021 Blue Book of E-cigarette Retail Industry" at IECIE.


2FIRSTS, a global professional media outlet in the electronic cigarette industry, focuses on market trends and development hot topics in the vaping field. Their commitment is to facilitate global communication of information on the industry and use their media influence to help the vaping industry develop worldwide. IECIE is a global exhibition platform for the e-cigarette vertical field. Through a partnership between 2FIRSTS and IECIE, the influence of the Jakarta Vape Expo will be expanded while also increasing global attention on the Southeast Asian e-cigarette market, ultimately promoting the development of the vaping industry in the region.


According to reports, the IECIE exhibition is moving overseas for the first time, choosing a venue in the rapidly developing Southeast Asian market. With the rapid growth of the global electronic vapor market in recent years, Southeast Asia has become a "new favorite" of the industry due to its population and market potential. According to Euromonitor data, it is expected that the total electronic vapor market in Southeast Asia will grow by 29% to reach $766 million by 2023. Indonesia, as the second-largest tobacco market in Asia, has 56.3 million tobacco product users, and its electronic vapor market value reached $239 million in 2021. It is a relatively mature market in Southeast Asia, and is expected to continue to grow.


The exhibition will take place at the Jakarta International Expo in Indonesia, covering an area of over 12,000 square meters. It will showcase a variety of electronic cigarettes and other products within the industry chain, attracting an estimated 10,000 visitors. More than 100 exhibitors, including well-known electronic cigarette brands such as Yooz, Yogi, SnowPlus, Laimi and Smoore, will be participating. Some of these brands will launch new products during the exhibition.


The IECIE Indonesia Jakarta Electronic Cigarette Exhibition will be closely monitored by 2FIRSTS, who will provide live updates throughout the event. The media company has previously reported on high-profile tobacco and e-cigarette expos in Germany, the United States, and the United Kingdom, establishing news centers in London, New York, and Moscow. Based on their professional reporting capabilities, 2FIRSTS will focus on the Southeast Asian e-cigarette market, capturing the latest industry developments and offering reliable sources of information for Chinese e-cigarette companies seeking to expand into Southeast Asia.


As a well-known international exhibition organizer in the industry, IECIE will continue to expand its international reach after the Jakarta exhibition in Indonesia, with upcoming exhibitions to be held in Malaysia, the United States, and other regions. 2FIRSTS, as IECIE's global partner and friendly collaborator, will continue to cover and report on these events.


Introduction to 2FIRSTS: Founded in 2021, 2FIRSTS is a company that specializes in providing compliance and global development services to electronic cigarette companies. The company is headquartered in Shenzhen, China and is a strategic partner of the Electronic Cigarette Committee, providing high-quality compliance and global development services to the industry. With capabilities in areas such as marketing, research, public relations, and data analysis, 2FIRSTS is committed to supporting the continuous development of the global new tobacco industry partners, including Chinese tobacco companies, and ultimately becoming an indispensable service provider in the global new tobacco industry chain.


As a member of the renowned exhibition group, Informa, IECIE is a globally influential trade show platform in the e-cigarette industry. With a focus on global perspectives and a vast network of domestic and international exhibitors and buyers, IECIE has taken a significant step forward in partnership with exhibitors and business partners by announcing its move overseas and expansion to the US and Europe within the next three years. The upcoming IECIE overseas exhibitions are expected to cover over 50,000 square meters with 1,000+ brands and 60,000+ professional attendees, serving as an important link for the global market by connecting Asia, Europe, and America.


1. This article is solely for internal industry discussion and exchange and does not promote or recommend any specific brands or products. 2. Smoking is harmful to health. Minors are prohibited from reading this article.


This article is an original piece by Shenzhen 2FIRSTS Technology Co., Ltd., and its copyright and licensing rights belong to the company. Any unauthorized copying, reproduction, or infringement of the company's copyright in any way by any individual or entity is prohibited, and the company retains the right to pursue legal action against violators.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13
Malaysia Police Seize RM12.7 Million in Illegal Vapes and Cigarettes as Probe Points to Sea Shipments From China
Malaysia Police Seize RM12.7 Million in Illegal Vapes and Cigarettes as Probe Points to Sea Shipments From China
Police in Malaysia’s Selangor state seized illegal vape products and contraband cigarettes worth about RM12.7 million (approximately $3 million) in two enforcement operations. According to New Straits Times and The Star, the vape-related operation uncovered 131,036 boxes of vape products, 4,900 bottles of e-liquid and 25,510 vape devices, valued at about RM9.4 million. Police said preliminary investigations indicated that some illegal vape products entered Malaysia through sea shipments from China before moving through storage and distribution networks.
Aug.10
Scotland Plans to Remove Business Rates Relief From Vape Shops From 2027
Scotland Plans to Remove Business Rates Relief From Vape Shops From 2027
The Scottish Government plans to remove business rates relief from vape shops from April 1, 2027, saying the measure is intended to ensure vape retailers contribute to the high street and align rates relief with public health commitments, while the impact on convenience stores that sell vaping products remains unclear.
News
Jun.26 by 2Firsts Perspectives
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13